Skip to main content
Erschienen in: Herz 3/2015

01.05.2015 | e-Herz: Original article

From changes in local RAAS to structural remodeling of the left atrium

A beautiful cycle in atrial fibrillation

verfasst von: Q. Yongjun, S. Huanzhang, Z. Wenxia, T. Hong, X. Xijun

Erschienen in: Herz | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Aims

In earlier studies, we reported structural remodeling was associated with atrial fibrillation (AF) and showed that the renin–angiotensin–aldosterone system (RAAS) was linked to AF. It is reasonable to hypothesize that there is a cycle, from RAAS to structural remodeling to AF.

Patients and methods

Our study group consisted of 80 patients scheduled for mitral valve replacement surgery. Tissue samples of the left atrial appendages were obtained. Masson’s trichrome staining and immunohistochemical staining were performed to assess the extent of fibrosis. Radioimmunoassay was carried out to investigate the expression levels of local RAAS. RAAS-related genes were analyzed by RT-PCR.

Results

There was a significantly increased degree of fibrosis in AF patients compared with sinus rhythm (SR) patients (p = 0.023). There were significant differences in the expression levels of local angiotensin (Ang) II between the SR and the AF groups (p = 0.002). The expression levels of local Ang II correlated with the duration of AF (r = 0.727851, p = 0.001) and with collagen type I (r = 0.672189, p = 0.032). In the AF group, the mRNA expressions of the AT1R and ACE genes were markedly up-regulated in comparison with the SR group (p = 0.021 and p = 0.037).

Conclusions

On the basis of this study, and in combination with results of our previous studies, we demonstrate for the first time that there is a cycle involving RAAS, structural remodeling, and AF. RAAS, structural remodeling, and AF are the principal aspects in this cycle.
Literatur
1.
Zurück zum Zitat Burstein B, Nattel S (2008) Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51:802–809CrossRefPubMed Burstein B, Nattel S (2008) Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51:802–809CrossRefPubMed
2.
Zurück zum Zitat Zhang S (2009) Atrial fibrillation in mainland China: epidemiology and current management. Heart 95:1052–1055CrossRefPubMed Zhang S (2009) Atrial fibrillation in mainland China: epidemiology and current management. Heart 95:1052–1055CrossRefPubMed
3.
Zurück zum Zitat Li Y, Jian Z, Yang ZY et al (2013) Increased expression of connective tissue growth factor and transforming growth factor-Beta-1 in atrial myocardium of patients with chronic atrial fibrillation. Cardiology 124(4):233–240CrossRefPubMed Li Y, Jian Z, Yang ZY et al (2013) Increased expression of connective tissue growth factor and transforming growth factor-Beta-1 in atrial myocardium of patients with chronic atrial fibrillation. Cardiology 124(4):233–240CrossRefPubMed
4.
Zurück zum Zitat Oliveira IM de, Oliveira BD, Scanavacca MI et al (2013) Fibrosis, myocardial crossings, disconnections, abrupt turns, and epicardial reflections: do they play an actual role in human permanent atrial fibrillation? A controlled necropsy study. Cardiovasc Pathol 22(1):65–69CrossRefPubMed Oliveira IM de, Oliveira BD, Scanavacca MI et al (2013) Fibrosis, myocardial crossings, disconnections, abrupt turns, and epicardial reflections: do they play an actual role in human permanent atrial fibrillation? A controlled necropsy study. Cardiovasc Pathol 22(1):65–69CrossRefPubMed
5.
Zurück zum Zitat Qian YJ, Meng J, Tang H et al (2010) Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases. Europace 12(3):371–377CrossRefPubMed Qian YJ, Meng J, Tang H et al (2010) Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases. Europace 12(3):371–377CrossRefPubMed
6.
Zurück zum Zitat Qian YJ, Liu Y, Tang H et al (2013) Circulating and local renin-angiotensin-aldosterone system express differently in atrial fibrillation patients with different types of mitral valvular disease. J Renin Angiotensin Aldosterone Syst 14:204–211CrossRefPubMed Qian YJ, Liu Y, Tang H et al (2013) Circulating and local renin-angiotensin-aldosterone system express differently in atrial fibrillation patients with different types of mitral valvular disease. J Renin Angiotensin Aldosterone Syst 14:204–211CrossRefPubMed
7.
Zurück zum Zitat Qian YJ, Shao HZ, Luo TX et al (2008) Plasma angiotensin converting enzyme level and permanent atrial fibrillation with mitral valvular disease. Lab Medicine 39(11):674–677CrossRef Qian YJ, Shao HZ, Luo TX et al (2008) Plasma angiotensin converting enzyme level and permanent atrial fibrillation with mitral valvular disease. Lab Medicine 39(11):674–677CrossRef
8.
Zurück zum Zitat Swartz MF, Fink GW, Sarwar MF et al (2012) Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation. J Am Coll Cardiol 60(18):1799–1806CrossRefPubMedCentralPubMed Swartz MF, Fink GW, Sarwar MF et al (2012) Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation. J Am Coll Cardiol 60(18):1799–1806CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat Nattel S, Burstein B, Dobrev D (2008) Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythmia Electrophysiol 1:62–73CrossRef Nattel S, Burstein B, Dobrev D (2008) Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythmia Electrophysiol 1:62–73CrossRef
10.
Zurück zum Zitat Polyakova V, Miyagawa S, Szalay Z et al (2008) Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med 12:189–208CrossRefPubMedCentralPubMed Polyakova V, Miyagawa S, Szalay Z et al (2008) Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med 12:189–208CrossRefPubMedCentralPubMed
12.
Zurück zum Zitat Marchesi C, Rehman A, Rautureau Y et al (2013) Protective role of vascular smooth muscle cell PPARgamma in angiotensin II-induced vascular disease. Cardiovasc Res 97(3):562–570CrossRefPubMed Marchesi C, Rehman A, Rautureau Y et al (2013) Protective role of vascular smooth muscle cell PPARgamma in angiotensin II-induced vascular disease. Cardiovasc Res 97(3):562–570CrossRefPubMed
13.
Zurück zum Zitat Singh JP, Kulik A, Levin R et al (2012) Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease. Europace 14(9):1287–1293CrossRefPubMed Singh JP, Kulik A, Levin R et al (2012) Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease. Europace 14(9):1287–1293CrossRefPubMed
14.
Zurück zum Zitat Disertori M, Barlera S, Staszewsky L et al (2012) Systematic review and meta-analysis: renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope. Cardiovasc Drugs Ther 26(1):47–54CrossRefPubMed Disertori M, Barlera S, Staszewsky L et al (2012) Systematic review and meta-analysis: renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope. Cardiovasc Drugs Ther 26(1):47–54CrossRefPubMed
15.
Zurück zum Zitat Kiryu M, Niwano S, Niwano H et al (2012) Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model. Europace 14(8):1206–1214CrossRefPubMedCentralPubMed Kiryu M, Niwano S, Niwano H et al (2012) Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model. Europace 14(8):1206–1214CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Dai HL, Guo Y, Guang XF et al (2013) The changes of serum angiotensin-converting enzyme 2 in patients with pulmonary arterial hypertension due to congenital heart disease. Cardiology 124(4):208–212CrossRefPubMed Dai HL, Guo Y, Guang XF et al (2013) The changes of serum angiotensin-converting enzyme 2 in patients with pulmonary arterial hypertension due to congenital heart disease. Cardiology 124(4):208–212CrossRefPubMed
17.
Zurück zum Zitat Kang SJ, You A, Kwak MK (2011) Suppression of Nrf2 signaling by angiotensin II in murine renal epithelial cells. Arch Pharm Res 34(5):829–836CrossRefPubMed Kang SJ, You A, Kwak MK (2011) Suppression of Nrf2 signaling by angiotensin II in murine renal epithelial cells. Arch Pharm Res 34(5):829–836CrossRefPubMed
18.
Zurück zum Zitat Kaschina E, Grzesiak A, Li J et al (2008) Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 118(24):2523–2532CrossRefPubMed Kaschina E, Grzesiak A, Li J et al (2008) Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 118(24):2523–2532CrossRefPubMed
19.
Zurück zum Zitat Yang KC, Jay PY, McMullen JR, Nerbonne JM (2012) Enhanced cardiac PI3Kalpha signalling mitigates arrhythmogenic electrical remodelling in pathological hypertrophy and heart failure. Cardiovasc Res 93(2):252–262CrossRefPubMedCentralPubMed Yang KC, Jay PY, McMullen JR, Nerbonne JM (2012) Enhanced cardiac PI3Kalpha signalling mitigates arrhythmogenic electrical remodelling in pathological hypertrophy and heart failure. Cardiovasc Res 93(2):252–262CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Qian YJ, Shao HZ, Zhou WX et al (2013) Histopathological characteristics and oxidative injury secondary to atrial fibrillation in the left atrial appendages of patients with different forms of mitral valve disease. Cardiovasc Pathol 22(3):211–218CrossRef Qian YJ, Shao HZ, Zhou WX et al (2013) Histopathological characteristics and oxidative injury secondary to atrial fibrillation in the left atrial appendages of patients with different forms of mitral valve disease. Cardiovasc Pathol 22(3):211–218CrossRef
21.
Zurück zum Zitat Topal NP, Ozben B, Hancer VS et al (2011) Polymorphisms of the angiotensin-converting enzyme and angiotensinogen gene in patients with atrial fibrillation. J Renin Angiotensin Aldosterone Syst 12(4):549–556CrossRefPubMed Topal NP, Ozben B, Hancer VS et al (2011) Polymorphisms of the angiotensin-converting enzyme and angiotensinogen gene in patients with atrial fibrillation. J Renin Angiotensin Aldosterone Syst 12(4):549–556CrossRefPubMed
Metadaten
Titel
From changes in local RAAS to structural remodeling of the left atrium
A beautiful cycle in atrial fibrillation
verfasst von
Q. Yongjun
S. Huanzhang
Z. Wenxia
T. Hong
X. Xijun
Publikationsdatum
01.05.2015
Verlag
Urban & Vogel
Erschienen in
Herz / Ausgabe 3/2015
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-013-4032-7

Weitere Artikel der Ausgabe 3/2015

Herz 3/2015 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.